Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122540762 | 12254076 | 2 | F | 201602 | 20160629 | 20160411 | 20160711 | EXP | US-ABBVIE-16K-163-1597341-00 | ABBVIE | 83.12 | YR | F | Y | 0.00000 | 20160710 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122540762 | 12254076 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | U | 1050493,1052418 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | |||||
| 122540762 | 12254076 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | U | 1050493,1052418 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | |||||
| 122540762 | 12254076 | 3 | SS | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
| 122540762 | 12254076 | 4 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
| 122540762 | 12254076 | 5 | C | DERMAZENE | HYDROCORTISONEIODOQUINOL | 1 | 0 | ||||||||||||
| 122540762 | 12254076 | 6 | C | DERMAZINC | 2 | 0 | CREAM | ||||||||||||
| 122540762 | 12254076 | 7 | C | FAMOTIDINE. | FAMOTIDINE | 1 | 0 | ||||||||||||
| 122540762 | 12254076 | 8 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 122540762 | 12254076 | 9 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 0 | ||||||||||||
| 122540762 | 12254076 | 10 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 122540762 | 12254076 | 11 | C | LOCOID | HYDROCORTISONE BUTYRATE | 1 | 0 | ||||||||||||
| 122540762 | 12254076 | 12 | C | LUTEIN | LUTEIN | 1 | 0 | ||||||||||||
| 122540762 | 12254076 | 13 | C | MYRBETRIQ | MIRABEGRON | 1 | 0 | ||||||||||||
| 122540762 | 12254076 | 14 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 122540762 | 12254076 | 15 | C | TRAVATAN | TRAVOPROST | 1 | 0 | ||||||||||||
| 122540762 | 12254076 | 16 | C | TRUSOPT | DORZOLAMIDE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 122540762 | 12254076 | 17 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 122540762 | 12254076 | 18 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | 0 | ||||||||||||
| 122540762 | 12254076 | 19 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 122540762 | 12254076 | 20 | C | ALBUTEROL. | ALBUTEROL | 1 | 0 | ||||||||||||
| 122540762 | 12254076 | 21 | C | AQUANIL | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122540762 | 12254076 | 1 | Psoriatic arthropathy |
| 122540762 | 12254076 | 3 | Product used for unknown indication |
| 122540762 | 12254076 | 4 | Product used for unknown indication |
| 122540762 | 12254076 | 5 | Product used for unknown indication |
| 122540762 | 12254076 | 6 | Product used for unknown indication |
| 122540762 | 12254076 | 7 | Product used for unknown indication |
| 122540762 | 12254076 | 8 | Product used for unknown indication |
| 122540762 | 12254076 | 9 | Product used for unknown indication |
| 122540762 | 12254076 | 10 | Product used for unknown indication |
| 122540762 | 12254076 | 11 | Product used for unknown indication |
| 122540762 | 12254076 | 12 | Product used for unknown indication |
| 122540762 | 12254076 | 13 | Product used for unknown indication |
| 122540762 | 12254076 | 14 | Product used for unknown indication |
| 122540762 | 12254076 | 15 | Product used for unknown indication |
| 122540762 | 12254076 | 16 | Product used for unknown indication |
| 122540762 | 12254076 | 17 | Product used for unknown indication |
| 122540762 | 12254076 | 18 | Product used for unknown indication |
| 122540762 | 12254076 | 19 | Product used for unknown indication |
| 122540762 | 12254076 | 20 | Product used for unknown indication |
| 122540762 | 12254076 | 21 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122540762 | 12254076 | Arthralgia | |
| 122540762 | 12254076 | Drug effect decreased | |
| 122540762 | 12254076 | Drug ineffective | |
| 122540762 | 12254076 | Gait disturbance | |
| 122540762 | 12254076 | Incorrect dose administered | |
| 122540762 | 12254076 | Mobility decreased | |
| 122540762 | 12254076 | Psoriasis | |
| 122540762 | 12254076 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122540762 | 12254076 | 1 | 201512 | 201604 | 0 | |
| 122540762 | 12254076 | 2 | 20160618 | 0 |